Impact of antagonist peptides and chelators on the diagnostic performance of PET/CT using gallium-68–labeled somatostatin receptor antagonists

Impact of antagonist peptides and chelators on the diagnostic performance of PET/CT using gallium-68–labeled somatostatin receptor antagonists

Objective:. Different SSTR2 antagonists have been developed. This study aims to evaluate the impact of different peptides and chelators on the diagnostic performance of SSTR2 antagonists in well-differentiated NETs. Methods:. In this prospective study, participants were equally randomized into 2 arm...

Full description

Bibliographic Details
Main Authors:	Haiqun Xing, Wenjia Zhu, Yuejuan Cheng, Qiao Yang, Ru Jia, Hong Zhao, Chunmei Bai, Li Huo, Wenming Wu
Format:	Article
Language:	English
Published:	Wolters Kluwer Health/LWW 2023-03-01
Series:	Journal of Pancreatology
Online Access:	http://journals.lww.com/10.1097/JP9.0000000000000101

Similar Items

Positron Emission Tomographic Imaging of Copper 64– and Gallium 68–Labeled Chelator Conjugates of the Somatostatin Agonist Tyr-Octreotate
by: Jessie R. Nedrow, et al.
Published: (2014-09-01)

The tetraamine chelator outperforms HYNIC in a new technetium-99m-labelled somatostatin receptor 2 antagonist
by: Keelara Abiraj, et al.
Published: (2018-08-01)

The utility of gallium-68 DOTATOC PET/CT in lymphangioleiomyomatosis
by: Brian Gaffney, et al.
Published: (2021-10-01)

Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68
by: Ruslan Cusnir, et al.
Published: (2017-01-01)

Gallium-68 labelled RGD PET/CT imaging of endothelial activation in COVID-19 patients
by: Evelien A. J. van Genugten, et al.
Published: (2023-07-01)

The effects of novel macrocyclic chelates on the targeting properties of the 68Ga-labeled Gastrin releasing peptide receptor antagonist RM2
by: Yinwen Wang, et al.
Published: (2023-06-01)

Incidental detection of a tumour on 68-Gallium DOTANOC PET/CT
by: Hina J Shah, et al.
Published: (2014-01-01)

Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer
by: Nat P. Lenzo, et al.
Published: (2018-02-01)

Alpha-peptide receptor radionuclide therapy using actinium-225 labeled somatostatin receptor agonists and antagonists
by: Mengqi Shi, et al.
Published: (2022-12-01)

Preclinical characterisation of gallium-68 labeled ferrichrome siderophore stereoisomers for PET imaging applications
by: Kristyna Krasulova, et al.
Published: (2024-03-01)

Targeted Prostate Biopsy Using 68Gallium PSMA-PET/CT for Image Guidance
by: Demetrios N. Simopoulos, et al.
Published: (2017-09-01)

Diagnostic Impact of Dual-Time PET/CT with <sup>68</sup>Gallium-PSMA in Prostate Cancer and <sup>68</sup>Gallium-DOTATOC in Neuroendocrine Tumors
by: Damiano Librizzi, et al.
Published: (2023-03-01)

Somatostatin receptor scintigraphy with <sup>68</sup>Ga-DOTATATE PET/CT: initial experience in Cuba
by: Juan P. Oliva González
Published: (2017-06-01)

PET imaging of CXCR4 using copper-64 labeled peptide antagonist
by: Orit Jacobson, Ido D. Weiss, Lawrence P. Szajek, Gang Niu, Ying Ma, Dale O. Kiesewetter, Joshua M. Farber, Xiaoyuan Chen
Published: (2011-01-01)

Gallium-68 Ventilation/Perfusion PET-CT and CT Pulmonary Angiography for Pulmonary Embolism Diagnosis: An Interobserver Agreement Study
by: Romain Le Pennec, et al.
Published: (2021-02-01)

Gastrin-Releasing Peptide Receptor Antagonist [<sup>68</sup>Ga]RM2 PET/CT for Staging of Pre-Treated, Metastasized Breast Cancer
by: Kerstin Michalski, et al.
Published: (2021-12-01)

Detection of neuroendocrine tumour of sphenoid sinus on the Gallium-68 DOTATATE PET/CT: a rare entity
by: Shamim, Syed Ejaz, et al.
Published: (2022)

The Impact of 68Gallium DOTA PET/CT in Managing Patients With Sporadic and Familial Pancreatic Neuroendocrine Tumours
by: Daniel J. Cuthbertson, et al.
Published: (2021-06-01)

Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4
by: Simon A. M. Kaeppeli, et al.
Published: (2019-05-01)

<sup>68</sup>Gallium-labelled PSMA-PET/CT as a diagnostic and clinical decision-making tool in Asian prostate cancer patients following prostatectomy
by: Janice S.H. Tan, et al.
Published: (2019-03-01)

Prevalence and significance of incidental findings on 68 Ga-DOTA-conjugated somatostatin receptor-targeting peptide PET/CT: a systematic review of the literature
by: Morten Bentestuen, et al.
Published: (2022-09-01)

Use of full-dose contrast-enhanced CT for extrahepatic staging using Gallium-68-DOTATATE PET/CT in patients with neuroendocrine tumors
by: Jonas Apitzsch, et al.
Published: (2021-07-01)

18F-FDG and 68Ga-somatostatin analogs PET/CT in patients with Merkel cell carcinoma: a comparison study
by: Silvia Taralli, et al.
Published: (2018-07-01)

Preclinical PET Imaging of Tumor Cell Death following Therapy Using Gallium-68-Labeled C2Am
by: Flaviu Bulat, et al.
Published: (2023-03-01)

Preclinical study of a new 177Lu-labeled somatostatin receptor antagonist in HT-29 human colorectal cancer cells
by: Hossein Behnammanesh, et al.
Published: (2020-07-01)

Gallium radiopharmaceuticals 68
by: José Morín Zorrilla, et al.
Published: (2012-01-01)

Synthesis and Physicochemical Properties of Cefepime Derivatives Suitable for Labeling with Gallium-68
by: Przemysław Koźmiński, et al.
Published: (2023-04-01)

Does treatment with somatostatin analogs differ in the uptake of normal target organs and malignant lesions on 68Ga-DOTATATE PET/CT imaging?
by: Çağlagül Erol, et al.
Published: (2022-08-01)

Bifunctional gallium cation chelators
by: A. G. Polivanova, et al.
Published: (2022-06-01)

A generator-produced gallium-68 radiopharmaceutical for PET imaging of myocardial perfusion.
by: Vijay Sharma, et al.
Published: (2014-01-01)

Effect of the versatile bifunctional chelator AAZTA5 on the radiometal labelling properties and the in vitro performance of a gastrin releasing peptide receptor antagonist
by: Michael Hofstetter, et al.
Published: (2020-11-01)

Comparative evaluation of 68Ga-labelled TATEs: the impact of chelators on imaging
by: Yuxiao Xia, et al.
Published: (2020-04-01)

Equilibrium Thermodynamics, Formation, and Dissociation Kinetics of Trivalent Iron and Gallium Complexes of Triazacyclononane-Triphosphinate (TRAP) Chelators: Unraveling the Foundations of Highly Selective Ga-68 Labeling
by: Adrienn Vágner, et al.
Published: (2018-05-01)

Simple, mild, one-step labelling of proteins with gallium-68 using a tris(hydroxypyridinone) bifunctional chelator: a 68Ga-THP-scFv targeting the prostate-specific membrane antigen
by: Saima Nawaz, et al.
Published: (2017-10-01)

Metastasectomy of Abdominal Wall Lesions due to Prostate Cancer Detected Through PET/CT Gallium 68-PMSA: First Case Report
by: Claudia Ochoa, et al.
Published: (2017-05-01)

A methodological investigation of healthy tissue, hepatocellular carcinoma, and other lesions with dynamic 68Ga-FAPI-04 PET/CT imaging
by: Barbara Katharina Geist, et al.
Published: (2021-01-01)

Preparation and PET/CT imaging of implant directed 68Ga-labeled magnetic nanoporous silica nanoparticles
by: Andras Polyak, et al.
Published: (2023-08-01)

In Vivo Trafficking of the Anticancer Drug Tris(8-Quinolinolato) Gallium (III) (KP46) by Gallium-68/67 PET/SPECT Imaging
by: Afnan M. F. Darwesh, et al.
Published: (2023-10-01)

A new 68Ga-labeled somatostatin analog containing two iodo-amino acids for dual somatostatin receptor subtype 2 and 5 targeting
by: Rosalba Mansi, et al.
Published: (2020-08-01)

Evaluation of agonist and antagonist radioligands for somatostatin receptor imaging of breast cancer using positron emission tomography
by: Iulia Dude, et al.
Published: (2017-04-01)